Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

HIV-RNA measurements in individual patients were performed throughout treatment, providing information on the virologic efficacy of ART in children. Furthermore, genotypic resistance testing for ...

Harmony Garges, M.D, senior vice president, chief medical officer and head of global medical at ViiV Healthcare, highlighted ...

Report with the AI impact on market trends- The global sexually transmitted disease (STD) testing market size is estimated to ...

Nucleic acid testing for neonatal diagnosis is restricted in resource-limited settings. Assays of HIV RNA are more sensitive than those for DNA, but can produce false positive results ...

Revolutionary liquid biopsy offers non-invasive disease detection, monitoring, and personalized treatment, especially in ...

Early detection is critical when it comes to curing diseases like cancer, but not everyone has easy access to screening tools ...

Kidney transplant between donors and recipients with HIV is successful, research shows, which may help addresses the organ ...

According to a new study from scientists at The University of Texas at Arlington, Chan-Zuckerberg Biohub, and Stanford ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Early detection is critical when it comes to curing diseases like cancer, but not everyone has easy access to screening tools.

OncoPrism is a solid tumor predictive diagnostic test that evaluates a patient's tumor immune profile against Cofactor’s high-dimensional RNA-based Health Expression Models (HEMs) to predict a ...